Dry Eye Academic Summit Opens | HWBIO's MeiboRevive™ Vectored Thermal Pulsation System Debuts Live at DRC2026, Co‑shaping the Future of Dry Eye Care

April 24, 2026, Chengdu – The much‑anticipated DRC2026 (Dry Eye Rehabilitation Annual Conference 2026) grandly opened today at the Intangible Cultural Heritage Expo Park Tivoli Hotel in Chengdu. As a premier annual event in the field of dry eye rehabilitation, DRC2026 brings together top ophthalmologists, clinical practitioners, and industry innovators from across China to focus on new technologies for dry eye diagnosis and treatment, novel rehabilitation concepts, and clinical practice pathways – jointly advancing the standard of dry eye care in the country to a higher level.

1. Gathering in the Academic Capital of Chengdu to Explore New Frontiers in Dry Eye

DRC2026 is hosted by the China National Health Association, the Second Affiliated Hospital of Zhejiang University School of Medicine, and the Eye & ENT Hospital of Fudan University. Centered on high‑level academic exchange and cutting‑edge technology showcases, the event serves as a bridge for deep integration of medical practice, industry, academia, and research, injecting strong momentum into upgrading dry eye diagnosis and treatment in China.

On the first day of DRC2026, HWBIO made a strong debut with its flagship product – the MeiboRevive™ Vectored Thermal Pulsation System. Drawing on its leading technological advantages and professional service experience, the HWBIO exhibition booth attracted numerous ophthalmologists, clinicians, and industry partners who came to learn about the innovative principles and clinical value of vectored thermal pulsation technology. Consultations and business discussions were brisk throughout the day.

2. Wetlab Live Demonstration – Intuitive Showcase of Technical Strength

On the afternoon of the first day of DRC2026, HWBIO presented its vectored thermal pulsation technology in a Wetlab live demonstration. Dr. Wang Lijuan from Zhejiang University Eye Hospital was invited as the lead operator. Through a combination of 'on‑site hands‑on operation + live online broadcast', the event provided a comprehensive, immersive walkthrough of the standardized treatment procedure.

• Expert endorsement: Dr. Wang Lijuan, with extensive clinical experience in ophthalmology and dry eye care, meticulously explained the synergistic mechanism of 'precise heating + pulsed massage' of vectored thermal pulsation therapy. She covered everything from treatment operation standards to clinical indication selection and patient experience optimization, delivering a high‑quality clinical practice session.
  
• High‑energy live broadcast: Step‑by‑step breakdowns were detailed and clear, with online and on‑site viewership continuously rising. The entire treatment process for MGD‑related dry eye was vividly demonstrated – using precision temperature control to gently soften obstructing meibum and rhythmic pulsed massage to unblock the meibomian glands, effectively addressing the root cause of dry eye.
  

3. Innovative Technology Empowers Solutions to Core Dry Eye Challenges

HWBIO remains committed to clinical needs and continuous innovation in high‑end ophthalmic medical devices. The debut at DRC2026 is not only a showcase of the company's technological strength and innovations but also an important practice in bridging clinical application, serving patients and physicians, and promoting deeper industry‑academia‑research integration.

As HWBIO’s flagship product, the MeiboRevive™ Vectored Thermal Pulsation System leverages proprietary core technologies to precisely target MGD‑induced dry eye. It leads the field of physical dry eye therapy with three key advantages:

1. Precision temperature control – safe and efficient: Proprietary temperature control technology delivers consistent heating to the meibomian gland area, safely softening obstructive meibum.
   
2. Pulsed massage – deep clearance: Rhythmic pulsed massage mimics expert manual techniques, deeply unblocking the meibomian glands, promoting lipid expression, and restoring a healthy tear film.
   
3. Standardized workflow – clinically adaptable: A fully standardized design makes the system easy to operate and suitable for diverse clinical settings such as dry eye clinics, helping clinics efficiently implement dry eye care.
   

4. Exploring New Pathways for Dry Eye Rehabilitation – HWBIO Walks with You

DRC2026 runs through April 26, 2026. HWBIO cordially invites all ophthalmology colleagues to visit Booth B13, 3rd Floor, Chengdu Intangible Cultural Heritage Expo Park Tivoli Hotel, to experience the MeiboRevive™ vectored thermal pulsation technology firsthand. Together, let us explore innovative paths for dry eye diagnosis and treatment and build a brighter, clearer future for vision.